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Abstract     This study determined if the co-ingestion of carbohydrate (CHO) with branched-chain amino acids 
(BCAA) or L-leucine (LEU) preferentially affected serum IGF-1 and the expression of myogenic-related genes in 
response to resistance exercise (RE). Forty one, college-age males were randomly assigned to 1 of 4 groups: CHO, 
CHO-BCAA, CHO-LEU, or placebo (PLC). Resistance exercise consisted of 4 sets of leg press and leg extension at 
80% 1RM. Supplements were ingested peri-exercise, and venous blood and muscle biopsies were obtained pre-
exercise (PRE), and at 30, 120, and 360 min post-exercise. Serum IGF-1 was determined with ELISA, and skeletal 
muscle mRNA expression of myostatin, ActRIIB, p21kip, p27kip, CDK2, cyclin B1, cyclin D1, Myo-D, myogenin, 
MRF-4, and myf5 was determined using real-time PCR. Results were determined with two-way ANOVA for serum 
IGF-1 and two-way MANOVA for mRNA expression. Serum IGF-1 in CHO and CHO+BCAA was greater than 
PLC (p < 0.05) but was not affected by RE (p > 0.05). Significant differences were detected between groups for my-
ostatin, ActIIB, MyoD, and myf5 mRNA expression showing CHO to be significantly different than CHO+BCAA, 
CHO+LEU, and PLC (p < 0.05). At 30, 120 and 360 min post-exercise, p21cip was significantly less than PRE, 
whereas cyclin D1 was greater than PRE at 120 and 360 min post-exercise (p < 0.05). The co-ingestion of CHO with 
either BCAA or L-leucine in conjunction with RE had no preferential effect on serum IGF-1 or pre-translational 
markers indicative of myogenesis. 
 




Skeletal muscle exhibits inherent plasticity in its 
ability to adapt to various mechanical, hormonal, 
and nutritional stimuli by possessing the capabil-
ity to alter its phenotype. Moreover, the ability of 
skeletal muscle to undergo hypertrophic changes 
in respone to resistance exercise is under the con-
trol of anabolic and catabolic signaling pathways 
that operate at both the pre- and post-
translational levels to help maintain the balance 
between protein synthesis and proteolysis. Two 
primary cellular processes are involved with hy-
pertrophy responses in mammalian skeletal mus-
cle. The first process involves both pre- and post-
translational mechanisms that result in the accre-
tion of myofibrillar protein and subsequent myo-
fiber enlargement due to increases in the myonu-
clear domain (Bickel et al. 2005; Shelmadine et 
al. 2009). The second process results in myofiber 
enlargenment due to a decreased myonuclear 
domain resulting from activation and prolifera-
tion of myogenic satellite cells which fuse into 
muscle fibers, thereby providing additional myo-
nuclei for augmented transcriptional activity and 
subsequent protein synthesis (Han et al. 2008). 
Muscle damage that occurs in response to re-
sistance exercise from both dynamic/isotonic 
(Willoughby & Nelson, 2002; Psilander et al. 
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2003) and forced-lengthening (eccentric) muscle 
contractions (Farup et al. 2014) have been shown 
to effectively increase markers of satellite cells 
activity and/or the number of activated satellite 
cells. 
Muscle protein accretion, mediated by satel-
lite cell activation, is modulated by the motiotic 
and myogenic activity of insulin-like growth fac-
tor 1 (IGF-1), which functions in an endo-
crine/autocrine/paracrine mode and functions 
through the binding to the IGF-1 receptor (IGF-
1R). This ligand-receptor interaction triggers in-
tracellular signaling cascades through extracellu-
lar-regulated kinase (ERK) and protein kinase B 
(Akt) which play a role in the proliferation and 
differentiation, respectively, of satellite cells 
(Philippou et al. 2007). Upon activation, however, 
the process of myogenesis is controlled by sever-
al myogenic regulatory factors (MRFs) which 
serve as transcription factors and act as terminal 
effectors of the signaling cascades and produce 
appropriate stage-specific transcripts. The expan-
sion of activated satellite cells occurs from myo-
genic factor 5 (myf5). Myoblast determination 
protein (Myo-D) is involved in determining the 
differentiation poteintial of an activated myoblast 
and acts together with myogenin to drive differ-
entiation, whereas muscle-specific regulatory 
factor 4 (MRF-4) is required for hypertrophy as 
it plays a role in the maturation of myotubes 
(Knight & Kothary, 2011).  
Along with the MRFs, the myogenic activa-
tion of satellite cells is also regulated by cyclin-
dependent kinases (CDKs) which have a catalyt-
ic dependence on the cyclin family of regulatory 
proteins. Cyclin D, a G1 cyclin which regulates 
progression through G1 and entry into the S 
phase of the cell cycle, is responsible for its role 
in myoblast differentiation by activating CDK2 
(Knight & Kothary, 2011). For myoblasts to dif-
ferentiate, the cell cyle must be exited and the 
restraints the CDKs place on differentitation 
must be removed. As such, the expression of cy-
clin D1, cyclin B1, and CDK2 decreases with 
differentiation (Jahn et al. 1994; Skapek et al. 
1995). 
Concomitant with the decreased expression 
of cyclin/CDKs, there is an increase in the levels 
of the cyclin-dependent kinase-interacting pro-
tein/kinase-inhibitory protein family (CIP/KIP). 
The CIP/KIPs, p21cip and p27kip, inhibit all G1 
CDKs (Knight & Kothary, 2011). Furthermore, 
myostatin which is a member of the transforming 
growth factor beta (TGF-β) family works in a 
paracrine/autocrine manner through the activin 
IIB receptor (ACTRIIB), and is a negative regu-
lator of myogenesis and subsequent muscle pro-
tein accretion by repressing the expression of 
Myo-D, myogenin, myf5, and p21cip, and by 
down-regulating cyclin D1 during the G1 phase 
of the cell cycle (Langley et al. 2002). 
Nutrients, amino acids in particular, play an 
important role in regulating muscle protein ac-
cretion. Moreover, delivery and uptake of carbo-
hydrate (CHO) and protein may influence satel-
lite cell activity, as it has recently been shown 
that both nutrients increased the number of satel-
lite cells per myonuclei during recovery follow-
ing eccentric exercise (Farup et al. 2014). The 
mechanism(s) in which nutrient availability may 
increase myogenic activity is not well known but 
may be associated with the process in which 
CHO and branched-chain amino acids (BCAAs) 
contained in protein are able to increase muscle 
protein synthesis (Miller et al. 2003) and up-
regulate intramuscular signaling cascades known 
to effect myogenic regulators such as ERK (Di 
Camillo et al. 2014) and Akt (Ferreira et al. 
2014). Relative to the role that nutrient availabil-
ity plays in inducing muscle hypertrophy, it has 
been shown that the immediate ingestion of ei-
ther CHO and/or amino acids after resistance ex-
ercise results in an increase in skeletal muscle 
protein synthesis (Biolo et al. 1997; Miller et al. 
2003). The branched-chain amino acids 
(BCAAs), in particular leucine, simulate protein 
synthesis through signalling pathways involving 
mTOR (mammalian target of rapamycin) (Kim-
ball & Jefferson, 2006; Rennie, 2007) in a dose-
response manner and seems independent of se-
rum insulin and IGF-1. Furthermore, we have 
previously shown that the insulinogenic response 
from the co-ingestion of CHO and BCAA insti-
gated no related response to RE in mediating in-
creases in the activity of Akt, mTOR, and 
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P70S6K, signaling markers indicative of muscle 
protein synthesis (Ferreira et al. 2014). 
However, currently there appear to be no 
published data available to elucidate the effects 
that CHO and BCAAs may have on the gene ex-
pression of myogenic markers on satellite cell 
activation in response to resistance exercise in 
humans. Therefore, the purpose of the study was 
to determine the effects of the co-ingestion of 
CHO with either BCAA or LEU in response to a 
single bout of heavy exercise on serum IGF-1 
and the skeletal muscle expression of the myo-
genically-related genes, myostatin, ActRIIB, 
p21cip, p27kip, CDK2, cyclin B1, cyclin D1, 
MyoD, myogenin, MRF-4, and myf5. 
METHODS 
Experimental Design 
The study involved a fully-randomized, four-
group, factorial, repeated-measures design in 
which each group received a separate peri-
exercise nutritional supplement while performing 
an identical bout of resistance exercise. Blood 
and muscle samples were obtained immediately 
before and 30, 120, and 360 min following exer-
cise. These data presented herein are a subset 
from our previous study in which a more com-
prehensive discussion of the methods, illustration 
of study timeline, and various data, such as se-
rum insulin and dietary intake, is presented else-
where (Ferreira et al. 2014). 
Participants 
A total of 46 individuals were screened for eligi-
bility in the study. Five individuals were not in-
cluded in the study for the following reasons: 
two did not meet inclusion criteria, one chose not 
to participate due to the muscle biopsies, and two 
chose not to participant due to time constraints. 
Therefore, 41 physically-active, apparently-
healthy men between the ages of 18-30 years 
served as participants in the study. While the 
men were physically active (engaging in non-
structured activity of a physical nature), they 
were not resistance-trained. Participants were 
excluded if they had been performing a struc-
tured resistance training program more than 
thrice weekly in the previous year and/or who 
had performed lower-body resistance exercise in 
the 14 days immediately prior to the study. Only 
participants considered as either low or moderate 
risk for cardiovascular disease and with no con-
traindications to exercise as outlined by the 
American College of Sports Medicine (Whaley, 
2005) and/or who had not consumed any nutri-
tional supplements (excluding multi-vitamins 
and protein supplements) one month prior to the 
study were allowed to participate. All 41 partici-
pants who began were able to successfully com-
pleted the study without any complications.  
Familiarization Session, Baseline Strength 
Testing, and Randomization to Groups 
During the familiarization session, participants 
received both written and verbal description of 
the study design and requirements and read and 
signed university-approved documents granted 
by the Institutional Review Board for Human 
Subjects of Baylor University. Height and body 
mass measures were obtained, then participants 
had their one repetition maximum (1-RM) de-
termined on the angled leg press (Nebula Fitness, 
Inc., Versailles, OH) and knee extension (Body 
Masters, Inc., Rayne, LA) exercises as previous-
ly described (Ferreira et al. 2014). After baseline 
strength testing, each subject was matched ac-
cording to muscle strength and body mass and 
then randomly assigned to one of four supple-
ment groups [CHO (n = 10), CHO + BCAA 
(n = 10), CHO + LEU (n = 11), placebo (n = 10)].  
Resistance Exercise Session Protocol 
Participants arrived at the lab in the morning be-
tween 8-10 am following an overnight fast, ade-
quately hydrated, and rested (no lower-body ex-
ercise for 72 hours prior to baseline testing). Par-
ticipants brought a completed 48-hr food record 
to the resistance exercise session. Participants 
performed four sets each of the angled leg press 
and knee extension exercises at 80% 1-RM until 
failure (approximately 8-12 repetitions). Rest 
periods were 2.5 min between both sets and ex-
ercises constituted a 1:5 work to rest ratio. The 
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exercise session was approximately 30 min in 
duration (Ferreira et al. 2014).  
Supplementation Protocol 
The BCAA supplement (Now Foods, Blooming-
dale, IL) was comprised of 50% leucine, 25% 
isoleucine, and 25% valine. The orally ingested 
dosage of BCAA was 120 mg/kg body mass (60 
mg/kg leucine, 30 mg/kg isoleucine, and 30 
mg/kg valine per each participant) (Karlsson et al. 
2004). The LEU supplement (Source Naturals, 
Scotts Valley, CA) was provided at a dosage of 
120 mg/kg per each participant. The amount of 
maltodextrin in the CHO supplement for each 
group was provided at a dosage of 1.5 g/kg body 
mass (approximately 120 g per each participant), 
which had been shown to induce a significant 
insulogenic response (Schumm et al. 2008). The 
placebo (PLC) supplement was non-caloric Crys-
tal Light®. Each supplement was ingested in 
equal parts dissolved in 150 mL of a flavored 
non-caloric beverage (of Crystal Light®), for a 
total supplement ingestion of 450mL. Partici-
pants ingested the assigned supplement dose at 
each of the following time points: 30 min prior to 
RE, immediately prior to RE, 5 min following 
RE. 
Venous Blood Sampling and Muscle Biopsies 
Venous blood was collected from the antecubital 
vein using a vacutainer apparatus and standard 
phlebotomy procedures. Vacutainer tubes were 
immediately centrifuged at 1,100 g for 15 
minutes (Cole Parmer, Vernon Hills, IL). Serum 
was then separated and transferred in sterile 
cryo-vials and stored at -80°C for future analyses.  
Upon subcutaneous anesthetization with 1% 
lidocaine, muscle biopsies (~50-75 mg) were ex-
tracted from the left vastus lateralis midway be-
tween the patella and the greater trochanter at a 
depth of 1-2 cm using the percutaneous biopsy 
technique with suction as previously described 
(Bergstrom, 1975; Evans et al. 1982; Ferreira et 
al., 2014). The same incision location was used 
for the subsequent excisions, and sampling depth 
was verified by depth markings on the biopsy 
needle. Following the initial biopsy, for each 
subsequent biopsy the needle was rotated in the 
clock-wise direction from the previous biopsy 
(biopsy 1 = 1,200 hours; biopsy 2 = 1,500 hours; 
biopsy 3 = 1,800 hours; biopsy 4 = 2,100 hours) 
so the sample was taken from within the same 
area of muscle. Previous research has shown that 
a multiple biopsy technique does not alter exer-
cise-induced gene expression (Lundby et al. 2005; 
Willoughby & Nelson, 2002). Collected muscle 
tissue samples were placed in sterile cryovials, 
flash frozen in liquid nitrogen, and stored at -80º 
C for future analysis. Blood and muscle samples 
were obtained immediately prior (PRE) to the 
first bolus of supplement, and at 30, 120, and 360 
min following RE. 
Serum IGF-1 
Serum IGF-1 was analyzed using a commercially 
available ELISA kit (Diagnostic Systems La-
boratories Inc. Webster, TX). According to the 
manufacturer, the sensitivity for this assay was 
0.01ng/mL. A standard curve was generated us-
ing a control peptide and absorbances were de-
termined in duplicate at an optical density of 450 
nm with a microplate reader (Wallac Victor 1420, 
Perkin Boston, MA, USA). IGF-1 concentrations 
were quantified using MicroWin microplate data-
reduction software (Mikrotek Laborysteme, 
Germany). The overall intra-assay coefficient of 
variation was 7.1%. 
Skeletal Muscle Total RNA Isolation and 
Quantitation and cDNA Synthesis 
Following our previously established procedures 
(Wilborn et al. 2009; Willougbhy et al. 2007), 
approximately 20 mg of muscle tissue was ho-
mogenized in a of monophasic solution of phenol 
and guanidine isothiocyanate contained within 
the TRI-reagent (Sigma Chemical Co., St. Louis, 
MO). Total RNA concentrations were deter-
mined spectrophotometerically (Helio γ, Thermo 
Electron, Milford, MA) by optical density (OD) 
at 260 nm using an OD260 equivalent to 40 
μg/μl (Ausubel et al. 2002), and the final concen-
tration expressed relative to muscle wet weight. 
Aliquots of total RNA were separated with 1% 
agarose gel electrophoresis, ethidium bromide 
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stained, and monitored under an ultraviolet light 
(Chemi-Doc XRS, Bio-Rad, Hercules, CA) to 
verify RNA integrity and absence of RNA deg-
radation, indicated by prominent 28s and 18s ri-
bosomal RNA bands, as well as an 
OD260/OD280 ratio of approximately 2.0. Test-
retest reliability of performing this procedure of 
total RNA integrity on samples in our laboratory 
has demonstrated low mean coefficients of varia-
tion and high reliability (1.8%, intraclass 
r = 0.96). The RNA samples were stored at -
80°C until later analysis. 
Total skeletal muscle RNA was reverse-
transcribed to synthesize cDNA using the iScript 
cDNA Synthesis Kit (Bio-Rad, Hercules, CA, 
USA). The cDNA concentration was determined 
by using an OD260 equivalent to 50 μg/μl (Au-
subel et al. 2002), and the starting cDNA tem-
plate concentration was standardized by adjust-
ing all samples to 200 ng prior to PCR amplifica-
tion (Wilborn et al. 2009; Willoughby et al. 
2007). 
Oligonucleotide Primers for PCR 
The mRNA sequences of human skeletal muscle 
published in the NCBI Entrez Nucleotide data-
base (www.ncdi.nlm.hih.gov) were used to con-
struct oligonucleotide PCR primers with Beacon 
Designer software (Bio-Rad, Hercules, CA, USA) 
(Table 1). Primer pairs were synthesized com-
mercially (Integrated DNA Technologies, Coral-
ville, IA). β-actin was used as an external control 
standard for each reaction due to its considera-
tion as a constitutively expressed "housekeeping 
gene," and the fact that it has been shown to be 
an appropriate external reference standard in re-
al-time PCR in human skeletal muscle following 
acute exercise (Mahoney et al. 2004; Wilborn et 
al. 2009; Willoughby et al. 2007).  
 
 
Table 1. Nucleotide sequences of sense and antisense primers used for real-time PCR. 
 
Primer Name NCBI Accession Number 
Sense Sequence 
(5' → 3') 
Anti-Sense Sequence 
(5' → 3') 
Amplicon Size 
(bp) 
β-Actin NM_001101 ATCGTGCGT GACATTAAG 
GTCATCACC 
ATTGGCAAT 102 
Myostatin NM_005259 CAAGAAYAGAAG CCATTAAGATAC 
CGTTGTAGCG 
TGATAATCG 194 
ActRIIB NM_001106 GCCTTGCCAT CAGATTGTG 
GCCATCAGAAC 
CAGATATACC 155 
Cyclin B1 NM_031966 TGCCTCTCCA AGCCCAATG 
TTCCTCAAGTTGT 
CTCAGATAAGC 178 
Cyclin D1 NM_001758 CAACTTCCTG TCCTACTACC 
TCCTCCTCC 
TCCTCTTCC 177 
CDK2 X61622 GCACTACGAC CCTAACAAG 
CCACCTGAGT 
CCAAATAGC 190 
P21cip L25610 TCCAGCGACCT TCCTCATCCAC 
TCCATAGCCTCT 
ACTGCCACCATC 108 
p27kip NM_004064 CAGGAGAGC CAGGATGTC 
TAGAAGAATC 
GTCGGTTGC 175 
Myo-D X56677 CGCCACCGC CAGGATATG 
GTCATAGAAGT 
CGTCCGTTGTG 108 
Myogenin X62155 TGAGGAGGTAAC ATAGAAGGACAG 
CAGCAGCCG 
TGGTCAGAG 148 
MRF-4 NM_002469 ACTGGCTCCTAT TTCTTCTACTTG 
TTCCTCTCC 
GCTGCTGTC 159 
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Real-Time PCR Amplification and Quantita-
tion 
Following our previous procedures (Wilborn et 
al., 2009; Willoughby et al. 2007), each reaction 
was amplified using real-time quantitative PCR 
system (iCycler IQ Real-Time PCR Detection 
System, Bio-Rad, Hercules, CA, USA). To help 
control for differences in amplification efficiency 
during thermocycling, all PCR reactions were 
prepared from the same stock solution. The spec-
ificity of the PCR was demonstrated with an ab-
solute negative control using a separate PCR re-
action containing no cDNA and a single gene 
product was confirmed for each primer pair using 
DNA melt curve analysis. Additionally, to assess 
positive amplification of mRNA and correct am-
plicon size, random aliquots of PCR reaction 
mixtures from each sample were agarose gel 
electrophoresed stained with ethidium bromide 
and ultra-violetly illuminated (Chemi-Doc XRS, 
Bio-Rad, Hercules, CA). Based on our previous 
work, the relative expression of mRNA was de-
termined as the ratio of the threshold cycle (Ct) 
values of each target mRNA to the corresponding 
Ct values of β-actin for each muscle sample (Ser-
ra et al. 2012; Wilborn et al., 2009; Willoughby 
et al. 2007). Test-retest reliability of performing 
this procedure of mRNA expression on samples 
in our laboratory has demonstrated low mean co-
efficients of variation and high reliability (1.6%, 
intraclass r = 0.95). 
Statistical Analyses 
A one-way analysis of variance (ANOVA) was 
calculated on all dependent variables to deter-
mine if significant differences existed at baseline 
between the four groups. A one-way ANOVA 
was performed on exercise volume for the four 
groups. A 4 × 4 (group × time point) univariate 
ANOVA was performed for serum IGF-1. A 4 × 
4 (group × time point) multivariate ANOVA 
(MANOVA) was determined on skeletal muscle 
mRNA variables. Due to the likelihood that the 
expression of our targeted genes were possibly 
being contingent on one another, the use of a 
MANOVA analysis prevented the chance of 
committing a Type I error that could result from 
the use of repeated univariate ANOVA; in con-
trast, this would increase the likelihood of per-
forming type II error, particularly with a low 
sample size. Separate ANOVAs on each depend-
ent variable were conducted as follow-up tests to 
the MANOVA. To control for alpha-level infla-
tion, the Bonferroni test was utilized for multiple 
comparisons.    
In addition to reporting probability values, an 
index of effect size was reported to reflect the 
magnitude of the observed effect. The index of 
effect size utilized was partial Eta squared (η2), 
which estimates the proportion of variance in the 
dependent variable that can be explained by the 
independent variable. Partial Eta squared effects 
sizes were determined to be: weak = 0.17, medi-
um = 0.24, strong = 0.51, very strong => 0.70 as 
previously described by (O'Connor et al., 2007). 
In addition, for all statistical analyses not meet-
ing the sphericity assumption for the within-
subjects analyses, a Greenhouse-Geisser correc-
tion factor was applied to the degrees of freedom 
in order to increase the critical F-value to a level 
that would prevent the likelihood of committing 
a type I error. All statistical procedures were per-
formed using SPSS 21.0 software (Chicago, IL) 




Descriptive statistics (means ±SD) for body mass, 
age, and height, are reported in Table 2. No sig-
nificant differences were found to exist at base-
line between groups for participant demographics, 
serum IGF-1, or any of the mRNA variables as-
sessed (p > 0.05).  
Total Lifting Volume and Macronutrient In-
take 
The mean ±SD exercise volume, expressed as 
total lifting volume for both the leg press and leg 
extension for the resistance exercise sessions was 
16,962 ±7,699 kg, 16,298 ±3,608 kg, 15,692 
±4,516 kg, and 17,784 ±6,600 kg for CHO, 
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CHO+BCAA, CHO+LEU, and PLC, respective-
ly. Results demonstrated no significant differ-
ences in exercise volume (p > 0.05). Data from 
nutritional intake is presented elsewhere (Ferreira 
et al. 2014), but was not significantly different 
between groups (p > 0.05).  
Serum IGF-1 
For serum IGF-1, results revealed no significant 
group × time interaction (p = 0.99; effects size = 
0.019) or main effect for time (p = 0.97; effect 
size = 0.004). However, a significant main effect 
for group was found (p = 0.001; effect size = 
0.135). Post-hoc analysis showed that CHO and 
CHO+BCAA were significant greater than PLC 
(Table 3).  
Skeletal Muscle mRNA Expression  
For the comprehensive multivariate analysis of 
all mRNA variables, Wilks’ Lambda produced a 
significant group × time interaction (p = 0.001; 
effect size = 1.00). There were also significant 
multivariate differences for the main effects for 
group (p = 0.001; effect size = 1.00) and time 
(p = 0.001; effect size = 1.00). 
 
Table 2. Participant Demographics. 
 
Demographics CHO CHO+BCAA CHO+LEU PLC p ≤ 0.05 
Height (cm) 183.3 ±6.5 178.0 ±5.4 178.1 ±8.4 178.1 ±9.0 0.32 
Body Mass (kg) 81.4 ±14.0 77.3 ±15.3 81.8 ±16.9 83.0 ±11.2 0.83 
Age (yrs) 20.4 ±2.5 21.8 ±2.6 20.7 ±3.2 21.0 ±2.4 0.69 
 
Data are reported as means ±SD.  No significant differences were found between groups at baseline relative to participant demographics (p > 0.05). 
 
 
Table 3. Serum IGF-1 Levels for the CHO, CHO+BCAA, CHO+LEU, and PLC Groups. 
 
Variable Pre 30 Min Post-Ex 120 Min Post-Ex 360 Min Post-Ex G T G×T 
IGF-1 (ng/ml)         0.001* 0.97 0.99 
CHO 337.35 ±112.49 305.01 ±90.09 327.78 ±87.03 338.49 ±91.42 > PLC   
CHO+BCAA 345.89 ±91.70 397.41 ±141.34 360.82 ±81.07 349.52 ±89.33 > PLC   
CHO+LEU 302.95 ±115.37 303.05 ±92.27 275.09 ±72.79 270.01 ±67.59    
PLC 257.61 ±69.90 275.62 ±88.85 267.68 ±87.28 267.16 ±84.92       
 
Data are presented as means ±SD for the serum values of IGF-1. G, T, and GxT represent the univariate main effects for group, time, and group x time inter-
action, respectively, at a probability level of ≤ 0.05.  The symbol * denotes a significant difference for the group main effect.  CHO and CHO+BCAA were 
significantly greater than PLC. 
 
mRNA Expression for Markers of Myogenic 
Activation 
Upon further analysis with univariate ANOVA, a 
significant group × time interaction was observed 
for cyclin D1 (p = 0.001; effect size = 1.00). 
Post-hoc analysis showed that PLC was signifi-
cantly greater than CHO, CHO+BCAA, and 
CHO+LEU at 30, 120, and 360 min post-exercise. 
Significant group main effects were observed for 
CDK2 (p = 0.002, effect size = 0.92), MyoD 
(p = 0.006; effect size = 0.86), and myf5 
(p = 0.007; effect size 0.85). For cyclin B1, a 
strong trend towards significance was observed 
base on a p-value of 0.06 and an effect size of 
0.60. Post-hoc analysis showed that for CDK2, 
CHO+BCAA, CHO+LEU, and PLC were signif-
icantly greater than CHO. In regard to Myo-D, 
CHO, CHO+LEU, and PLC were greater than 
CHO+BCAA. For myf5, CHO and CHO+BCAA 
were significantly greater than PLC and 
CHO+LEU. 
Analysis of the time main effects also pro-
duced significant differences between time points 
for cyclin B1 (p = 0.001; effect size = 0.986). 
Post-hoc analysis revealed that PRE was signifi-
cantly less than 30 and 120 min post-exercise. 
For MRF-4, a strong trend towards significance 
was observed base on a p-value of 0.07 and an 
effect size of 0.58. (Table 4). 
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Table 4. mRNA Expression for Markers of Myogenic Activation for the CHO, CHO+BCAA, CHO+LEU, and PLC Groups. 
 




Post-Ex G T G×T 
CDK2     0.002 * 0.88 0.76 
CHO 0.98 ±0.04 1.01 ±0.04 1.01 ±0.03 0.99 ±0.05    
CHO+BCAA 1.06 ±0.05 1.05 ±0.06 1.03 ±0.07 1.04 ±0.04 > CHO   
CHO+LEU 1.04 ±0.06 1.02 ±0.07 1.01 ±0.06 1.05 ±0.06 > CHO   
PLC 1.05 ±0.08 1.02 ±0.06 1.05 ±0.04 1.03 ±0.07 > CHO   
        
Cyclin B1  > PRE > PRE  0.06 0.001 † 0.13 
CHO 1.04 ±0.02 1.01 ±0.03 1.02 ±0.01 1.02 ±0.02    
CHO+BCAA 1.03 ±0.02 1.02 ±0.01 1.07 ±0.06 1.04 ±0.04    
CHO+LEU 1.04 ±0.05 1.01 ±0.02 1.04 ±0.03 1.05 ±0.04    
PLC 1.02 ±0.05 1.01 ±0.01 1.05 ±0.02 1.02 ±0.03    
        
Cyclin D1   > PRE, 30 MIN POST-EX 
> PRE, 30 MIN 
POST-EX 0.001 * 
0.001 
† 0.001 ‡ 
CHO 0.93 ±0.04 0.99 ±0.03 0.98 ±0.02 1.04 ±0.02 < PLC   
CHO+BCAA 1.00 ±0.04 0.98 ±0.02 1.01 ±0.03 1.00 ±0.01 < PLC   
CHO+LEU 0.98 ±0.03 0.95 ±0.02 1.01 ±0.01 1.03 ±0.03 < PLC   
PLC 0.99 ±0.03 1.01 ±0.03 1.04 ±0.02 1.06 ±0.04    
        
Myo-D     0.006 * 0.52 0.79 
CHO 1.07 ±0.09 1.04 ±0.07 1.05 ±0.08 1.05 ±0.07 > CHO+BCAA   
CHO+BCAA 1.00 ±0.05 1.02 ±0.09 0.97 ±0.07 0.99 ±0.06    
CHO+LEU 1.04 ±0.07 1.04 ±0.12 1.07 ±0.07 1.03 ±0.08 > CHO+BCAA   
PLC 1.07 ±0.06 1.02 ±0.09 1.02 ±0.06 1.01 ±0.05 > CHO+BCAA   
        
Myogenin     0.34 0.58 0.54 
CHO 1.12 ±0.10 1.11 ±0.06 1.09 ±0.10 1.11 ±0.11    
CHO+BCAA 1.08 ±0.09 1.08 ±0.10 1.09 ±0.12 1.07 ±0.10    
CHO+LEU 1.05 ±0.04 1.13 ±0.11 1.10 ±0.07 1.06 ±0.11    
PLC 1.21 ±0.06 1.14 ±0.07 1.06 ±0.08 1.10 ±0.04    
        
MRF-4     0.13 0.07 0.62 
CHO 1.20 ±0.15 1.19 ±0.15 1.19 ±0.18 1.20 ±0.17    
CHO+BCAA 1.20 ±0.12 1.18 ±0.11 1.20 ±0.14 1.16 ±0.12    
CHO+LEU 1.28 ±0.10 1.24 ±0.19 1.27 ±0.15 1.19 ±0.12    
PLC 1.03 ±0.10 1.31 ±0.12 1.23 ±0.13 1.12 ±0.12    
        
Myf5     0.007 * 0.26 0.30 
CHO 1.06 ±0.09 1.02 ±0.07 1.02 ±0.08 1.02 ±0.09 > PLC, CHO+LEU   
CHO+BCAA 1.01 ±0.05 1.03 ±0.07 1.04 ±0.09 1.00 ±0.06 > PLC, CHO+LEU   
CHO+LEU 1.08 ±0.05 1.06 ±0.07 1.07 ±0.05 1.01 ±0.07    
PLC 1.09 ±0.05 1.07 ±0.06 1.04 ±0.03 1.09 ±0.06    
 
Data are presented as means ±SD for the ratio of Ct values for β-actin and each target mRNA variable. G, T, and G×T represent the univariate main effects 
for group, time, and group × time interaction, respectively, at a probability level of ≤ 0.05.  The symbol * denotes a significant main effect for group.  For 
CDK2, CHO+BCAA, CHO+LEU, and PLC were significantly greater than CHO.  For cyclin D1, PLC was significantly different from CHO, CHO+BCAA, 
and CHO+LEU.  For MyoD, CHO+BCAA was significant different than CHO, CHO+LEU, and PLC.  For myf5 CHO and CHO+BCAA were significantly 
different from PLC, and CHO+LEU was significantly different from CHO+BCAA. The symbol † denotes a significant main effect for test. For cyclin B1, 
PRE was significantly less than 30, 120, and 360 min post-exercise.  The symbol ‡ denotes a significant group x time interaction.  PLC was greater than 
CHO, CHO+BCAA, and CHO+LEU at 120 and 360 min post-exercise. 
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Table 5. mRNA Expression Data for Markers of Myogenic Inhibition for the CHO, CHO+BCAA, CHO+LEU, and PLC 
Groups. 
 




Post-Ex G T G×T 
Myostatin     0.001 * 0.38 0.13 
CHO 1.04 ±0.11 1.00 ±0.10 0.98 ±0.09 0.99 ±0.07 > CHO+LEU, PLC   
CHO+BCAA 1.07 ±0.09 1.06 ±0.10 1.04 ±0.07 1.05 ±0.06 > CHO+LEU, PLC   
CHO+LEU 0.88 ±0.07 0.92 ±0.08 0.93 ±0.07 0.95 ±0.06    
PLC 0.84 ±0.06 0.89 ±0.05 0.95 ±0.06 0.98 ±0.04    
        
ACTRIIB     0.001 * 0.32 0.91 
CHO 1.06 ± 0.06 1.06 ±0.09 1.08 ±0.04 1.03 ±0.03    
CHO+BCAA 0.97 ±0.05 0.96 ±0.04 1.01 ±0.05 0.98 ±0.04 < CHO   
CHO+LEU 0.91 ±0.03 0.98 ±0.06 0.98 ±0.04 0.96 ±0.07 < CHO   
PLC 1.01 ±0.06 1.03 ±0.04 1.02 ±0.05 1.00 ±0.03 < CHO   
        
P21cip  > PRE > PRE > PRE 0.27 0.009 † 0.47 
CHO 1.03 ±0.03 1.05 ±0.06 1.08 ±0.10 1.08 ±0.11    
CHO+BCAA 1.03 ±0.10 1.05 ±0.09 1.04 ±0.08 1.04 ±0.05    
CHO+LEU 0.94 ±0.03 1.10 ±0.10 1.12 ±0.09 1.11 ±0.09    
PLC 1.04 ±0.03 1.10 ±0.09 1.10 ±0.07 1.11 ±0.06    
        
P27kip     0.37 0.37 0.73 
CHO 1.06 ±0.12 1.05 ±0.11 1.03 ±0.10 1.02 ±0.07    
CHO+BCAA 1.08 ±0.09 1.03 ±0.08 0.99 ±0.08 1.01 ±0.07    
CHO+LEU 1.02 ±0.03 1.09 ±0.11 1.08 ±0.06 1.03 ±0.05    
PLC 1.13 ±0.10 1.05 ±0.09 1.07 ±0.03 1.04 ±0.05    
 
Data are presented as means ±SD for the ratio of Ct values for β-actin and each target mRNA variable. G, T, and G×T represent the univariate main effects 
for group, time, and group × time interaction, respectively, at a probability level of  ≤ 0.05.  The symbol * denotes a significant main effect for group.  For 
myostatin, CHO and CHO+BCAA were significant greater than CHO+LEU and PLC. For ActRIIB, CHO was significantly greater than CHO+BCAA, 
CHO+LEU, and PLC, while CHO+LEU was greater than PLC.  The symbol † denotes a significant main effect for time.  PRE was significantly less than 30, 
120, and 360 min post-exercise. 
 
mRNA Expression for Markers of Myogenic 
Inhibition  
Upon further analysis with univariate ANOVA, 
signifcant group main effects were observed for 
myostatin (p = 0.001; effect size = 1.00) and 
ActIIB (p = 0.001; effect size = 0.99). Post-hoc 
analysis showed that for myostatin CHO and 
CHO+BCAA were significantly greater than 
CHO+LEU and PLC. For ActIIB, CHO was sig-
nificantly greater than CHO+BCAA, CHO+LEU, 
and PLC.  
Analysis of the time main effects also pro-
duced significant differences between time points 
for p21cip (p = 0.009; effect size = 0.829). Post-
hoc analysis showed that 30, 120, and 360 min 
post-exercise were significantly greater than PRE 
(Table 5). 
DISCUSSION 
The primary purpose of this study was to deter-
mine if the co-ingestion of carbohydrate with ei-
ther BCAA or L-leucine in conjunction with a 
single bout of resistance exercise had any prefer-
ential effect to placebo or carbohydrate or place-
bo on serum IGF-1 and skeletal muscle mRNA 
expression of markers involved in activiating and 
inhibiting myogenic activation of satellite cells. 
In general, we observed resistance exercise to 
have no effect on serum IGF-1, but there was an 
effect on the expression of several genes. How-
ever, we observed no preferential RE-induced 
effects from the ingestion of any of the supple-
ments for the variables assessed. 
Since IGF-1 is known to be a humoral myo-
genic activator based on its binding and subse-
quent activation of its respective transmembrane 
receptor, we were compelled to determine the 
responsiveness of serum IGF-1 to resistance ex-
ercise and/or CHO and amino acid ingestion. In 
the present study, the response in the supplement 
groups for serum IGF-1 was not related to RE. 
This is congruent with our previous work using 
the same resistance exercise protocol, which also 
revealed no exercise-induced effects on the he-
patically-derived release of IGF-1 (Taylor et al. 
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2012). An earlier study also demonstrated the 
unresponsiveness of serum IGF-1 to a single bout 
of resistance exercise (Kraemer et al. 1992).  
We also suspected that insulin may also play 
a role in myogenically-related gene expression 
by virtue of the role that insulin receptor sub-
strate 1 (IRS-1) autophosphorylation plays in in-
creasing ERK 1/2 and Akt-mTOR signaling rela-
tive to transcriptional and translational mecha-
nisms. Although not shown in the present study, 
our previous study (Ferreira et al. 2014) demon-
strated significant increases in serum insulin 
compared to PLC that peaked at the 30 min post-
exercise sampling point for both CHO-containing 
supplement groups. We observed the same re-
sponse for the CHO+LEU group in the present 
study. Furthermore, none of these three interven-
tion groups differed in regards to insulin levels 
(data not shown). Therefore, there were no pref-
erential interactive effects from exercise and nu-
tritional intervention on serum insulin or IGF-1. 
As a result, since there were no RE-related ef-
fects in any of the supplement groups on the ex-
pression of any of our targeted genes, the impact 
that either of these hormones played on the pre-
translational activation of our selected genes ap-
pears to be negligible. 
 A single bout of heavy RE is sufficient to 
induce a transient up-regulation of muscle-
specific gene expression (Wilborn et al. 2009; 
Willoughby & Nelson, 2002). Following a single 
bout of RE, the mRNA expression of the myo-
genic activators, Myo-D, myogenin, MRF-4, and 
myf5 were up-regulated at 30, 120, and 360 min 
post-exercise (Psilander et al. 2002; Wilborn et al. 
2009; Willoughby & Nelson, 2002), and Cyclin 
B1 was significantly up-regulated 24 hr post- ex-
ercise (Kim et al. 2005; Wilborn et al. 2009). In 
older men, Myo-D, myogenin, and p27kip have 
been shown to be unresponsive to a single bout 
of RE when assessed one hr post-exercise (Hulmi 
et al. 2007). In agreement with previous results, 
in the present study we observed RE-induced in-
creases in the mRNA expression of Cyclin B1 at 
30 and 120 min post-exercise and Cyclin D1 at 
120 and 360 min post-exercise. We also ob-
served a strong trend towards significance in re-
sponse to RE for MRF-4 based on p-value of 
0.07 and a corresponding effect size of 0.58, 
which suggests this gene to be somewhat respon-
sive to our RE intervention. Relatedly, in re-
sponse to 45 min of treadmill running at 77% of 
VO2max, MRF-4 was increased in human vastus 
lateralis 4 hr post-exercise, while myogenin was 
unaltered (Harber et al. 2009)  
A single bout of RE has also been shown to 
down-regulate the myogenic inhibitors, myo-
statin, and p27kip (Hulmi et al. 2008; Kim et al. 
2005; Wilborn et al. 2009). Additionally, tread-
mill running has also been shown to result in a 
decrease in myostatin mRNA expression at 240 
min post-exercise (Harber et al. 2009). However, 
in middle-aged men a single bout of RE has been 
shown to increase p21cip 60 min post-exercise 
(Hulmi et al. 2008). In older men, a single bout 
of RE exercise has been shown to down-regulate 
myostatin and ActIIB mRNA (Hulmi et al. 2007). 
Herein, we demonstrate a responsiveness to re-
sistance exercise, as p21cip mRNA was up-
regulated at 30, 120, and 360 min post-exercise.  
Relative to the intake of nutrients, previous 
investigations have demonstrated conflicting re-
sults regarding the immediate ingestion of amino 
acids and/or carbohydrate after endurance- and 
resistance-related exercise. For example, the in-
gestion of 8.6 g of BCAAs (7 g leucine) one hr 
following RE resulted in a decreased myostatin 
mRNA expression at 180 and 360 min post-
exercise. This occurred with concomitant in-
creases in myogenin at 180 and 360 min post-
exercise and Myo-D at 360 min post-exercise 
(Drummond et al. 2009). In middle-aged men, it 
was demonstrated that 15 g of whey isolate 
(~ 1.6 g of leucine) in conjunction with RE had 
no differential effect from placebo relative to the 
observed decreases in myostain mRNA expres-
sion at 60 min post-exercise (Hulmi et al. 2008). 
In addition, p21cip was increased at 60 min post-
exercise compared to baseline for placebo but not 
the whey protein group. Following 60 min of cy-
cle ergometry at 72% of VO2max during periods 
of either fasting or a meal containing 62 g of car-
bohydrate and approximately 9 g leucine, 5 g iso-
leucine, and 6 g valine, MRF-4 mRNA expres-
sion was increased at 120 and 360 min post-
exercise during the fasting condition only (Har-
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ber et al. 2010). In a study involving the inges-
tion of 10 g EAA (BCAA content equaling 3.5 g 
leucine, 0.8 g isoleucine, 1.0 g valine), but with 
no exercise intervention, myostatin mRNA was 
decreased and Myo-D increased 180 min post-
ingestion (Drummond et al. 2009).  
In the present study, we have attempted to 
delineate a possible preferential role that leucine 
might play compared to carbohydrate and/or 
BCAA in regards to the expression of genes in-
volved in myogenic activity of satellite cells. Our 
present results, along with a number of previous 
studies, have provided compelling evidence that 
various genes serving as markers of the myogen-
ic activity of satellite cells are load-sensitive, ir-
respective of muscle contractions involved in 
either resistance or endurance exercise. However, 
in line with previous studies our observation sub-
stantiate the lack of congruence that exists re-
garding the effectiveness of amino acid ingestion 
on pre-translational markers indicative of the 
myogenic activity of satellite cells.  
In the present study, the three experimental 
groups received the equivalent amount of carbo-
hydrate. The amino acid-containing groups both 
received the equivalent amount of leucine, which 
was provided at a relative dose of 60 mg/kg, and 
based on the range in body mass (approximately 
67-95 kg), constituted an approximate leucine 
dose in the range of 4-6 g. This is unlike the pre-
viously-mentioned studies which provided abso-
lute doses of amino acids and/or leucine ranging 
anywhere between 2-9 g. Based on the differ-
ences in macronutrient intakes, particularly ami-
no acids, attempting to confidently corroborate 
our results with previous studies is challenging. 
Relative to the intake of amino acids, with the 
exception of cyclin D1, we have shown no pref-
erential RE-induced effect from carbohydrate, 
BCAA, or L-leucine intake on serum IGF-1 or 
any of the gene targeted for analysis that are 
known markers in either the activation or inhibi-
tion of satellite cell activity. In regard to cyclin 
D1, in the absence of any carbohydrate and/or 
amino acid-induced effect on any of the other 
genes assessed, it is difficult to interpret the im-
portance of this result.  
Even though the role of carbohydrate and/or 
amino acids has not been conclusively demon-
strated, the present study helps to solidify the un-
derstanding regarding the effectiveness of re-
sistance exercise in regulating the pre-
translational activity of markers of satellite cell 
activity. Therefore, in light of the results present-
ed herein, we conclude that the co-ingestion of 
carbohydrate with either BCAA or L-leucine in 
conjunction with RE has no preferential effect on 
serum IGF-1 or pre-translational markers indica-
tive of myogenesis. 
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